Express News Quiz: World Cup, Gaza's tunnels and Diljit Dosanjh
The Indian Express' special news quiz helps you catch up on India and the world with 10 questions every Friday
Source: indianexpress.com
Major Headlines News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Major Headlines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Major Headlines Today - Breaking & Trending Today
Review of Patrick Ta Beauty
Using formulas that are both good for your skin and perfect for the red carpet in inclusive shade ranges, Patrick Ta has created the beauty brand of your dreams. His makeup is the most viral brand of 2023, with his cream-over-powder blush method taking the world by storm.
Source: popdust.com
Canopy Growth Corp (CGC), COMP SERVICES (CMPS), FIELD TRIP HEALTH LTD by Field Trip Health Ltd. (FTRPF), NUMINUS WELLNESS INC by NUMINUS WELLNESS INC. (LKYSD), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), Red White & Bloom Brands (RWBYF), Seelos Therapeutics, Inc. - Common Stock (SEEL) - Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories Of The Week
MindMed Will Use the Proceeds of the Offering for Investment in its Digital Medicine Division, for Further Investments in its Project Lucy and Project Layla, for its LSD Micro-Dosing ADHD Trials and for General Working Capital Purposes MindMed (OTCQB:MMEDF) announced that further to its previously announced offering on December 14 and December 15, 2020, it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec. Pursuant to the underwriting agreement among the company, the underwriters Canaccord Genui...
Source: benzinga.com
MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories Of The Week
Based on Positive Pre-IND Meeting With FDA, MindMed is Now Prepared to Open an Investigational New Drug (IND) in August 2021 With a Phase 2B Clinical Trial for LSD Assisted Therapy in Anxiety MindMed (OTCQB:MMEDF) announced the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. FDA regarding the development of LSD assisted therapy for an anxiety disorder. MindMed also provided a clinical development update on 18-MC announcing the firm continues to dose escalation of 18-MC in Phase I SAD/MAD and has confirmed a meeting with the FDA.
Source: benzinga.com